🇺🇸 FDA
Pipeline program

Modified-Release Prednisone

4554-A

Phase 2 small_molecule completed

Quick answer

Modified-Release Prednisone for Chronic Inflammation is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Chronic Inflammation
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials